Videau J Y
Réseau Médicaments Développement, ReMeD, Paris, France.
Med Trop (Mars). 2006 Dec;66(6):533-7.
Due to worsening economic conditions and poor enforcement of existing pharmaceutical and customs regulations, third world countries are faced with a growing threat from counterfeit and substandard medicines. With the expansion of illicit markets in urban areas, the sales of medicines of uncertain quality and origin are increasing. Most victims of this illicit trade are among the world's poorest populations that cannot afford to buy quality drugs through private-sector distribution channels. National pharmaceutical programs promoting universal access to essential generic medicines at reasonable cost are the key to curbing this problem. A system based on strict, rational pharmaceutical purchasing and distribution policies with quality assurance at every level of the supply chain is needed to guarantee that patients receive safe effective high quality healthcare products.
由于经济状况不断恶化以及现有药品和海关法规执行不力，第三世界国家正面临来自假冒伪劣药品的日益严重的威胁。随着城市地区非法市场的扩大，质量和来源不确定的药品销量不断增加。这种非法贸易的大多数受害者是世界上最贫困的人群，他们无力通过私营部门分销渠道购买质量可靠的药品。以合理成本促进普遍获得基本通用药品的国家药品计划是遏制这一问题的关键。需要一个基于严格、合理的药品采购和分销政策且在供应链各环节都有质量保证的系统，以确保患者能够获得安全、有效、高质量的医疗保健产品。
